Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.450
+0.020 (0.82%)
At close: Aug 13, 2025, 4:00 PM
2.440
-0.010 (-0.41%)
Pre-market: Aug 14, 2025, 8:45 AM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $162.99 million as of August 14, 2025. Its market cap has increased by 58.39% in one year.
Market Cap
162.99M
Enterprise Value
93.22M
1-Year Change
58.39%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since June 20, 2007, Cardiff Oncology's market cap has decreased from $1.11B to $162.99M, a decrease of -85.30%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 163.00M | -26.54% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 166.40% |
| Dec 30, 2011 | 36.90M | 5.73% |
| Dec 31, 2010 | 34.90M | -93.61% |
| Dec 31, 2008 | 546.30M | -50.74% |
| Dec 31, 2007 | 1.11B | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |